Creative BioMart to Present at
                        BIO-Europe Spring Creative BioMart to Present at AACR Annual Meeting|Apr. 5-10, 2024|Booth #2953

Cytochrome P450 1A2 Inhibitor Screening Kit

Cat.No. : Kit-2127
Product Overview : CYP1A2 Inhibitor Screening Kit enables rapid screening of drugs and other new chemical entities (NCEs) for compound-CYP1A2 interaction in a reliable, high-throughput fluorescence-based assay. The kit provides a yeast microsomal preparation of human CYP1A2 and human cytochrome P450 reductase (CPR) enzymes. The assay utilizes a non-fluorescent CYP1A2 substrate that is converted into a highly fluorescent metabolite detected in the visible range (Ex/Em = 406/468 nm), ensuring a high signal-to-background ratio with little interference by autofluorescence. The kit contains a complete set of reagents sufficient for performing 100 reactions in a 96- well plate format.
  • Specification
  • Gene Information
  • Related Products
Size : 100 assays
Applications : Rapid, high-throughput screening of drugs and novel ligands. Development of structure-activity relationship (SAR) models to predict CYP1A2 inhibition liability of novel compounds.Prediction of adverse drug-drug interaction potential and bioavailability for compounds metabolized by CYP1A2.
Storage : Store kit at -20°C and protected from light. Briefly centrifuge all small vials prior to opening. Allow the CYP1A2 Assay Buffer to warm to room temperature (RT) prior to use. Read entire protocol before performing the assay procedure.3-CHC Standard: Reconstitute in 110 µl of DMSO and vortex until fully dissolved to yield a 5 mM stock solution. The 3-CHC stock solution should be stored at -20°C and is stable for at least 3 freeze/thaw cycles.CYP1A2 Inhibitor (α-naphthoflavone): Reconstitute in 110 µl of acetonitrile and vortex until fully dissolved to yield a 1 mM stock solution. The stock solution is stable for 2 months at -20°C. To obtain a 30 µM working solution of α-naphthoflavone (5X final concentration), add 30 µl of the 1 mM stock solution to 970 µl of CYP1A2 Assay Buffer. The 30 µM working solution should be stored at -20°C and used within one week.NADPH Generating System (100X): Reconstitute with 110 µl CYP1A2 Assay Buffer, aliquot and store at -20°C. Avoid repeated freeze/thaw cycles. Keep on ice while in use.β-NADP+ Stock (100X): Dissolve in 110 µl CYP1A2 Assay Buffer and vortex thoroughly (100X stock). Store at -20°C, stable for at least 3 freeze/thaw cycles.CYP1A2 Substrate: Reconstitute with 110 µl anhydrous HPLC-grade acetonitrile and vortex until fully dissolved to obtain a 5 mM stock solution. Store at -20°C. When using the CYP1A2 Substrate stock solution, allow the vial to warm to RT before opening and promptly retighten cap after use to avoid absorption of airborne moisture.Recombinant Human CYP1A2: The Recombinant Human CYP1A2 should be reconstituted immediately before use as directed in Protocol.2 below. Each vial is sufficient for preparation of 50 reactions in a 96-well plate format.

For Research Use Only. Not intended for any clinical use. No products from Creative BioMart may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative BioMart.

Inquiry

  • Q&As
  • Reviews

Q&As (7)

Ask a question
How does CYP1A2 interact with other cytochrome P450 enzymes in metabolic pathways? 12/29/2022

CYP1A2 collaborates with other P450 enzymes in metabolic processes.

What is the impact of altered CYP1A2 activity on liver function and disease risk? 10/20/2022

Changes in CYP1A2 activity can affect liver health and disease risk.

How do genetic variations in CYP1A2 affect drug metabolism and response? 09/23/2021

Genetic differences in CYP1A2 influence drug metabolism and individual medication responses.

What is the primary role of CYP1A2 in xenobiotic metabolism? 09/06/2021

CYP1A2 is key in metabolizing drugs and environmental chemicals.

What role does CYP1A2 play in the detoxification of environmental toxins? 01/29/2020

CYP1A2 helps detoxify harmful environmental substances.

How does CYP1A2 contribute to the metabolism of caffeine and other dietary compounds? 06/08/2019

It metabolizes caffeine and certain dietary compounds, affecting their bodily impact.

What potential therapeutic applications arise from understanding CYP1A2 activity in personalized medicine? 08/11/2017

CYP1A2's role can inform personalized medicine, tailoring drug therapies to individual metabolic profiles.

Customer Reviews (3)

Write a review
Reviews
10/15/2022

    Enables data-driven decisions. Elevates research standards.

    08/02/2021

      Invaluable for insights. Highly recommended for research.

      10/23/2020

        Swift and accurate service. Supports research credibility.

        Ask a Question for All CYP1A2 Products

        Required fields are marked with *

        My Review for All CYP1A2 Products

        Required fields are marked with *

        0

        Inquiry Basket

        cartIcon
        logo

        FOLLOW US

        Terms and Conditions        Privacy Policy

        Copyright © 2024 Creative BioMart. All Rights Reserved.

        Contact Us

        • /

        Stay Updated on the Latest Bioscience Trends